Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance

AIDS Research and Human Retroviruses

Volumn 13, Issue 16, 1997, Pages 1403-1409

  Lori, F ^a   Malykh, A G ^a   Foli, A ^a   Maserati, R ^a   De Antoni, A ^a   Minoli, L ^a   Padrini, D ^a   Antoni, A D ^a   Barchi, E ^a   Jessen, H ^a   Wainberg, M A ^a   Gallo, R C ^a   Lisziewicz, J ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; HYDROXYUREA; LAMIVUDINE; NUCLEOSIDE ANALOG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENTIATION; DRUG TARGETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0030831543     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.1403     Document Type: Article

References (28)